Moneycontrol
Get App
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 20, 16:00
321.35 3.45 (1.09%)
Volume
AVERAGE VOLUME
5-Day
149,233
10-Day
102,377
30-Day
79,444
60,031
  • Prev. Close

    317.90

  • Open Price

    319.00

318.20

Today’s L/H

325.65
267.30

52 Wk L/H

667.00
286.15

L/U Price Band

349.65
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    322.55
     Beta
    0.56
  • Market Depth (20 Feb 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    200 321.95 323.00 237
    3250 321.90 323.15 200
    87 321.75 323.30 1500
    1500 321.70 323.45 20
    20 321.65 323.65 500
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Feb 20, 15:57
321.55 3.45 (1.08%)
Volume
AVERAGE VOLUME
5-Day
3,254,420
10-Day
2,254,446
30-Day
1,994,637
1,529,171
  • Prev. Close

    318.10

  • Open Price

    318.10

317.70

Today’s L/H

325.95
267.25

52 Wk L/H

666.80
286.30

L/U Price Band

349.90
  • Bid Price (Qty.)

    321.55 (664)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    322.53
     Beta
    0.62
  • DELIVERY AVERAGES
    3-Day
    12.69%
    5-Day
    13.78%
    8-Day
    14.23%
    Deliverables
  • SMA
    30
    331.59
    50
    337.84
    150
    348.52
    200
    392.05
    SMA
    331.59
Parameters
NSE
BSE
Bid Price
321.55
0.00
Bid Qty
664
0
Offer Price
0.00
0.00
Offer Qty
0
0
Today's Low
317.70
318.20
Today's High
325.95
325.65
52 Wk Low
267.25
267.30
52 Wk High
666.80
667.00
Open Price
318.10
319.00
Prev. Close
318.10
317.90
Expiry Date
323.90 4.55 ( 1.42 % )
Parameters
NSE
Open Price
318.80
High Price
326.85
Low Price
318.60
Prev. Close
319.35
Average Price
323.65
No. of Contracts Traded
1
Turnover (Rs. In Lakhs)
8,917.20
Market Lot
1400
Open Interest
7,344,400
Open Interest Change
25,200
Open Interest Change %
0.34
Expiry Date
Option Type
Strike Price
323.90 4.55 ( 1.42 % )
Parameters
NSE
Open Price
318.80
High Price
326.85
Low Price
318.60
Prev. Close
319.35
Average Price
323.65
No. of Contracts Traded
1
Turnover (Rs. In Lakhs)
8,917.20
Market Lot
1400
Open Interest
7,344,400
Open Interest Change
25,200
Open Interest Change %
0.34

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Bearish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 325.77 329.98 334.02 321.73 317.52 313.48 309.27
Fibonacci 324.88 326.83 329.98 321.73 318.58 316.63 313.48
Camarilla 322.31 323.06 323.82 321.73 320.79 320.04 319.28

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 319.16
10 322.84
20 322.48
50 337.84
100 326.64
200 392.05
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 341.07 348.33 359.37 330.03 322.77 311.73 304.47
Fibonacci 337.02 341.34 348.33 330.03 323.04 318.72 311.73
Camarilla 335.48 337.15 338.83 330.03 332.12 330.45 328.77

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 347.40 384.60 404.00 328.00 290.80 271.40 234.20
Fibonacci 349.62 362.98 384.60 328.00 306.38 293.02 271.40
Camarilla 315.39 320.58 325.76 328.00 305.01 299.82 294.64

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      9,067.47
    • P/E
      7.05
    • Book Value (Rs)
      423.23
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      33.12
    • EPS (TTM)
      45.6
    • P/C
      6.51
    • Price/Book
      0.76
    • Dividend Yield.(%)
      0.62
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      12.69
      5-Day
      13.78
      8-Day
      14.23
      15.45

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      9,067.47
    • P/E
      12.65
    • Book Value (Rs)
      198.63
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      33.12
    • EPS (TTM)
      25.42
    • P/C
      8.69
    • Price/Book
      1.62
    • Dividend Yield.(%)
      0.62
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      12.69
      5-Day
      13.78
      8-Day
      14.23
      15.45

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

F&O QUOTE

NSE 323.90 4.55 (1.42%)
Instrument Type
Expiry Date
Option Type
Strike Price
    • Open Price
      318.80
    • High Price
      326.85
    • Low Price
      318.60
    • Prev. Close
      319.35
    • Average Price
      323.65
    • No. of Contracts Traded
      1
    • Turnover (Rs. In Lakhs)
      8,917.20
    • Market Lot
      1400

Forum

Community Sentiments

  • 67% BUY
  • 33% SELL
  • 0% HOLD
67%
of moneycontrol users recommend buying Glenmark

What's your call on Glenmark today?

Read 3 investor views

BUY SELL HOLD

Action in Glenmark Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Feb 21, 09:15
319.00 1.10 (0.35%)
High 319.90
Low 319.00
Prev. Close 317.90

NSE

Feb 21, 09:15
318.10 0.00 (0.00%)
High 318.10
Low 317.65
Prev. Close 318.10

Financials

Income Statement

  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 1,816.29 1,742.62 1,455.23 1,530.76 1,599.90
Other Income 94.49 192.47 68.54 168.39 -84.64
PBDIT 413.55 380.53 308.64 268.74 349.36
Net Profit 345.53 431.99 227.84 281.29 195.87
  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 2,735.56 2,763.73 2,283.60 2,526.08 2,509.78
Other Income 32.96 80.83 1.67 39.06 -109.02
PBDIT 440.07 450.41 341.90 364.12 434.69
Net Profit 190.84 255.54 109.28 161.66 116.34

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 28.22 28.22
Networth 11,942.09 10,391.44
Total Debt 3,134.48 2,981.07
Net Block 1,413.48 1,699.12
Investments 3,268.75 3,212.68
Total Assets 15,076.56 13,372.51

Historical Prices

On
Current Price %Gain / Loss
Open Price 583.75 319.00
-45.35
High Price 590.00 325.65
-44.81
Low Price 580.10 318.20
-45.15
Close Price 586.95 317.90
-45.84
Volume 345,870 60,031
-82.64
On
Current Price %Gain / Loss
Open Price 579.60 318.10
-45.12
High Price 590.40 325.95
-44.79
Low Price 579.20 317.70
-45.15
Close Price 586.95 318.10
-45.8
Volume 435,907 1,529,171
250.8
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12080.90 -45.00 -0.37
SENSEX 41170.12 -152.88 -0.37
NIFTY BANK 30942.85 104.65 0.34
NIFTY IT 16649.40 -123.05 -0.73
S&P BSE Smallcap 14746.52 74.94 0.51
Index Price Change %Chg
Nasdaq (Feb 21) 9,635.64 -115.33 -1.18
DAX (Feb 21) 13,579.33 -84.67 -0.62
FTSE (Feb 21) 7,403.92 -32.72 -0.44
CAC (Feb 21) 6,029.72 -32.58 -0.54
SGX Nifty (Feb 21) 12,026.50 -8.00 -0.07

CORPORATE ACTION

Date Agenda
Feb 14, 2020 Quarterly Results & Others
Nov 14, 2019 Quarterly Results
Aug 13, 2019 Quarterly Results
May 29, 2019 Others
Type Dividend% Ex-Dividend date
Final 200.00 Sep 19, 2019
Final 200.00 Sep 19, 2018
Final 200.00 Sep 20, 2017
Final 200.00 Aug 03, 2016
Final 200.00 Sep 10, 2015
Ratio Announcement Date Ex-Bonus
1:1 Jan 06, 2005 Mar 04, 2005
Old FV New FV Ex-Split
2 1 Sep 10, 2007
10 2 Oct 23, 2003
Ratio Premium Ex-Bonus
No Rights Information is available for Glenmark Pharma
Date Agenda
Sep 27, 2019 -
Sep 27, 2018 -
Sep 28, 2018 -
Sep 29, 2017 -
Aug 12, 2016 Rs.2.0000 per share(200%)Dividend

Dividend Summary

For the year ending March 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 321.55 this results in a dividend yield of 0.62%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 December 2018 September 2018 June 2018
Promoters 46.58 46.54 46.54 46.54
Pledged 0 0 0 0
FII/FPI 31.04 32.27 30.9 30.61
Total DII 13.05 11.85 12.75 12.16
Fin.Insts 2.62 2.72 2.82 2.74
Insurance Co 0 0 0 0
MF 4.88 4.02 4.28 4.01
Others DIIs 5.55 5.11 5.65 5.41
Others 9.35 9.34 9.82 10.7
Total 100.02 100 100.01 100.01

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Glenmark 321.35 1.09 667.00 267.30 9067.47 6,304.87 1,622.11
Sun Pharma 404.90 0.41 484.10 350.40 97149.07 10,303.21 816.60
Divis Labs 2168.60 -0.73 2239.55 1466.95 57569.52 4,879.66 1,332.65
Dr Reddys Labs 3256.50 -0.62 3363.00 2352.00 54111.03 10,625.50 1,277.30
Torrent Pharma 2235.80 -0.26 2285.95 1453.00 37834.82 5,762.00 745.00

COMPANY OVERVIEW

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Karvy Computershare Private Ltd.

    • Address

      Plot no. 31-32, GachibowliFinancial DistrictNanakramguda

    • City

      Hyderabad 500032

    • State

      Telangana

    • Tel. No.

      040-23001153

    • Fax No.

    • Email

    • Internet

  • Management

    • Name

      Designation

    • Glenn Saldanha

      Chairman & Managing Director

    • V S Mani

      Executive Director & Global CFO

    • Rajesh V Desai

      Non Executive Director

    • B E Saldanha

      Non Executive Director

    • Bernard Munos

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      Yes

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Glenmark Pharma Ltd.

Glenmark is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Related Searches